Sretenovic A, Nikolic S, Krstovski N, Zdujic N, Slavkovic M, Dasic I
Healthcare (Basel). 2025; 13(5).
PMID: 40077022
PMC: 11898974.
DOI: 10.3390/healthcare13050460.
Ramos E, Marques H, Palavecino M, Pawlik T, Adam R, Soubrane O
Arq Bras Cir Dig. 2025; 37():e1858.
PMID: 39841763
PMC: 11745478.
DOI: 10.1590/0102-6720202400064e1858.
Sampath S, Patkar S, Agarwal J, Ghosh K, Shet T, Gala K
Indian J Surg Oncol. 2024; 15(Suppl 2):297-304.
PMID: 38817988
PMC: 11133300.
DOI: 10.1007/s13193-024-01884-3.
Alvarez F, Ardiles V, Chara C, de Santibanes M, Sanchez Claria R, Pekolj J
Updates Surg. 2024; 76(3):855-868.
PMID: 38647857
DOI: 10.1007/s13304-024-01835-1.
Wu Y, Guo J, Peng W
Langenbecks Arch Surg. 2023; 409(1):20.
PMID: 38153558
DOI: 10.1007/s00423-023-03211-w.
SALVAGE ALPPS PROCEDURE FOR FAILED PORTAL VEIN EMBOLIZATION.
Ferri J, Feier F, Scaffaro L, Maffazioli L, Hallal C, Kruel C
Arq Bras Cir Dig. 2023; 36:e1776.
PMID: 38055381
PMC: 10695179.
DOI: 10.1590/0102-672020230058e1776.
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS)-a fine balance.
Yeung K, Sodergren M
Hepatobiliary Surg Nutr. 2023; 12(2):269-271.
PMID: 37124686
PMC: 10129901.
DOI: 10.21037/hbsn-23-96.
Pushing the Limits of Surgical Resection in Colorectal Liver Metastasis: How Far Can We Go?.
Calderon Novoa F, Ardiles V, De Santibanes E, Pekolj J, Goransky J, Mazza O
Cancers (Basel). 2023; 15(7).
PMID: 37046774
PMC: 10093442.
DOI: 10.3390/cancers15072113.
Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry.
Serenari M, Ratti F, Guglielmo N, Zanello M, Mocchegiani F, Lenzi J
Surg Endosc. 2023; 37(7):5285-5294.
PMID: 36976422
DOI: 10.1007/s00464-023-09937-4.
[Treatment concepts for hepatic echinococcosis].
Denzinger M, Nasir N, Steinkraus K, Michalski C, Huttner F, Traub B
Chirurgie (Heidelb). 2023; 94(6):560-570.
PMID: 36853342
DOI: 10.1007/s00104-023-01825-w.
Impact of sarcopenia on the future liver remnant growth after portal vein embolization and associating liver partition and portal vein ligation for staged hepatectomy in patients with liver cancer: A systematic review.
Wang Q, Wang A, Li Z, Sparrelid E, Brismar T
Front Oncol. 2022; 12:1064785.
PMID: 36505848
PMC: 9730229.
DOI: 10.3389/fonc.2022.1064785.
Application of associating liver partition and portal vein ligation for staged hepatectomy for initially unresectable hepatocellular carcinoma.
Chen H, Wang X, Zhu W, Li Y, Yu Z, Li H
BMC Surg. 2022; 22(1):407.
PMID: 36434548
PMC: 9700990.
DOI: 10.1186/s12893-022-01848-w.
Physical prehabilitation improves the postoperative outcome of associating liver partition and portal vein ligation for staged hepatectomy in experimental model.
Daradics N, Levay K, Horvath I, Kovacs N, Mathe D, Szigeti K
Sci Rep. 2022; 12(1):19441.
PMID: 36376345
PMC: 9663729.
DOI: 10.1038/s41598-022-23744-2.
Parenchyma-Sparing Liver Resection or Regenerative Liver Surgery: Which Way to Go?.
Botea F, Barcu A, Kraft A, Popescu I, Linecker M
Medicina (Kaunas). 2022; 58(10).
PMID: 36295582
PMC: 9609602.
DOI: 10.3390/medicina58101422.
Current trends in regenerative liver surgery: Novel clinical strategies and experimental approaches.
Heil J, Schiesser M, Schadde E
Front Surg. 2022; 9:903825.
PMID: 36157407
PMC: 9491020.
DOI: 10.3389/fsurg.2022.903825.
Relationship of immunonutritional factor with changes in liver volume after portal vein embolization.
Nanashima A, Tanoue Y, Yano K, Hiyoshi M, Imamura N, Hamada T
Surg Open Sci. 2022; 9:117-124.
PMID: 35755162
PMC: 9218550.
DOI: 10.1016/j.sopen.2022.05.012.
Liver growth prediction in ALPPS - A multicenter analysis from the international ALPPS registry.
Lopez-Lopez V, Linecker M, Cruz J, Brusadin R, Lopez-Conesa A, Machado M
Liver Int. 2022; 42(12):2815-2829.
PMID: 35533020
PMC: 9796398.
DOI: 10.1111/liv.15287.
Associating liver partition and portal vein ligation for staged hepatectomy versus sequential transarterial chemoembolization and portal vein embolization in staged hepatectomy for HBV-related hepatocellular carcinoma: a randomized comparative study.
Li P, Huang G, Jia N, Pan Z, Liu H, Yang Y
Hepatobiliary Surg Nutr. 2022; 11(1):38-51.
PMID: 35284529
PMC: 8847855.
DOI: 10.21037/hbsn-20-264.
The Role of Farnesoid X Receptor in Accelerated Liver Regeneration in Rats Subjected to ALPPS.
Daradics N, Olthof P, Budai A, Heger M, van Gulik T, Fulop A
Curr Oncol. 2021; 28(6):5240-5254.
PMID: 34940077
PMC: 8700148.
DOI: 10.3390/curroncol28060438.
Sequential Portal Vein Embolization and Percutaneous Radiofrequency Ablation for Future Liver Remnant Growth: A Minimally Invasive Alternative to ALPPS Stage-1 in Treatment of Hepatocellular Carcinoma.
Wang Q, Ji Y, Brismar T, Chen S, Li C, Jiang J
Front Surg. 2021; 8:741352.
PMID: 34660682
PMC: 8515047.
DOI: 10.3389/fsurg.2021.741352.
